HALOZYME THERAPEUTICS, INC. (HALO) Balance sheet

Market cap

$7.9B

P/E ratio

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	53	100	27	61	43	67	169	58	121	148	119	235	118	116
Marketable securities, current	-	-	44	74	65	138	300	297	602	220	622	129	-	-
Total cash & short-term investments	53	100	72	136	108	205	470	355	723	369	741	363	118	116
Accounts receivable, net	2	16	9	9	32	16	22	30	59	98	91	231	-	-
Inventories	567,263	3	6	6	9	15	5	23	29	61	54	100	128	142
Total current assets	64	131	95	161	172	257	510	428	543	555	926	739	746	1,085
Property, plant and equipment, net	2	4	3	3	4	4	4	7	11	11	-	-	-	-
Total non-current assets	2	4	7	5	10	5	10	12	22	25	178	1,102	987	978
Total assets	66	135	102	166	182	262	520	440	566	580	1,104	1,842	1,733	2,063
Accounts payable	8	2	3	3	4	4	8	4	6	2	2	18	12	10
Long-term debt, current	-	-	-	-	22	17	77	92	20	397	89	13	-	-
Total current liabilities	17	19	25	24	62	55	131	149	86	421	117	131	112	139
Long-term debt, non-current	-	30	50	50	28	199	125	35	383	-	787	1,493	1,499	1,506
Total non-current liabilities	-	-	-	-	-	-	-	-	-	-	-	-	1,537	1,561
Total liabilities	-	-	-	-	-	-	-	-	-	-	-	-	1,649	1,700
Common stock and paid-in capital	103,990	112,709	115,000	0	0	0	0	0	0	0	0	0	0	0
Retained earnings	-245,021,646	-298,573,648	-382,052,199	-450	-483	-585	-522	-531	-604	-475	-59	143	91	360
Stockholders' equity	11	49	-19,990,676	41	43	-32	208	249	92	151	197	170	84	364
Total debt	-	30	50	50	50	217	202	126	403	397	877	1,506	1,499	1,506
Net debt	-	-70,239,584	-21,731,210	-86	-59	12	-267	-229	-320	29	135	1,143	1,381	1,390
D/E ratio (%)	-	60.7	-249	120.6	115.9	-666.9	97.1	50.8	438.7	263	445.1	887	1,788.9	413.9
Working capital													-	-